Fine Organic Industries Limited Earnings Summary — Q4 FY2026
Fine Organic Industries Reports Recovery in Q4 Profits and Sequential Margin Improvement
Key Takeaways
- Revenue for Q4 FY2026 grew by 3% YoY to ₹625 Cr, showing a strong sequential recovery of 12.6% over Dec 2025.
- Net Profit surged 58% sequentially to ₹117 Cr, bouncing back from a multi-quarter low in the December 2025 period.
- Operating margins recovered to 21% from late-2025 lows, though they remain compressed compared to the 26%+ levels seen in FY24.
- Other income contributed significantly this quarter at ₹35 Cr, aiding the bottom line amidst volatile raw material costs.
- The balance sheet remains exceptionally strong with reserves exceeding ₹2,600 Cr against a modest debt of ₹68 Cr.
- Inventory levels have risen to 104 days by the end of March 2026, contributing to a longer cash conversion cycle.
- Tax expense normalized to 18% in the latest quarter, significantly lower than the 25-27% seen in previous periods.
Management Guidance
Management remains focused on product diversification into feed nutrition and pharma additives while navigating global destocking cycles.
Sentiment Shift
Improving
A sharp rebound in net income and sequential revenue growth suggests the company is emerging from a period of demand normalization and margin pressure.
Outlook
The company is well-positioned for future growth in EU and USA markets due to its 'green chemistry' focus, though near-term performance depends on vegetable oil price stability.
From the Annual Report (Key Quotes)
“Dominant niche player in the oleochemical-based additives market.”
“Low-cost, debt-free operation underpinned by deep technical expertise.”
“Normalization reflects a stable bottom-up demand despite global destocking.”
Earnings Call Transcript — Q4 FY2026
Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.
This summary is AI-generated from Fine Organic Industries Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.